An open science pathway for drug marketing authorization-Registered drug approval.
oleh: Florian Naudet, Maximilian Siebert, Rémy Boussageon, Ioana A Cristea, Erick H Turner
| Format: | Article |
|---|---|
| Diterbitkan: | Public Library of Science (PLoS) 2021-08-01 |
Deskripsi
Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.